VESPULA THERAPEUTICS LTD

Active London

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
V

VESPULA THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 5 Oct 2023 Active London, England 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 30 Jun 2025 Next due 31 Jul 2026 2 months remaining
Confirmation Submitted 16 Oct 2025 Next due 18 Oct 2026 4 months remaining
Net assets £-554K
Total assets £618K
Total Liabilities £1M
Charges None No charges registered

Contact & Details

Contact

Registered Address

86-90 Paul Street London EC2A 4NE England

Full company profile for VESPULA THERAPEUTICS LTD (15191029), an active company based in London, England. Incorporated 5 Oct 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Nov → 31 Oct 2024
Type micro-entity
Next accounts 31 Oct 2025
Due by 31 Jul 2026 2 months remaining

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

N/A

Net Assets

-£553.86k

Total Liabilities

£1.17M

Turnover

N/A

Employees

N/A

Debt Ratio

190%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Oct Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 10,000 Shares £10k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Oct 202410,000£10k£1

Officers

Officers

2 active 1 resigned
Status
Christoph HessDirectorSwissSwitzerland555 Oct 2023Active
Dmitry KuzminDirectorBritishEngland395 Oct 2023Active

Shareholders

Shareholders (20)

4bio Ventures Ii L.p. Acting By Its General Partner 4bio Ventures Ii Gp Limited
47.9%
30,000
4bio Ventures Ii L.p. Acting By Its General Partner 4bio Ventures Ii Gp Limited
47.9%
30,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 5 Oct 2023
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

4BIO PARTNERS LLP united kingdom
VESPULA THERAPEUTICS LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
16 Oct 2025Confirmation StatementConfirmation statement made on 4 Oct 2025 with updates
30 Jun 2025AccountsAnnual accounts made up to 31 Oct 2024
7 Feb 2025OfficersTermination of Kyrylo Mudryy as director on 27 Jan 2025
7 Feb 2025OfficersAppointment of Mr Vasily Fedorin as director on 27 Jan 2025
17 Nov 2024ResolutionResolutions
16 Oct 2025 Confirmation Statement

Confirmation statement made on 4 Oct 2025 with updates

30 Jun 2025 Accounts

Annual accounts made up to 31 Oct 2024

7 Feb 2025 Officers

Termination of Kyrylo Mudryy as director on 27 Jan 2025

7 Feb 2025 Officers

Appointment of Mr Vasily Fedorin as director on 27 Jan 2025

17 Nov 2024 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 4 Oct 2025 with updates

7 months ago on 16 Oct 2025

Annual accounts made up to 31 Oct 2024

10 months ago on 30 Jun 2025

Termination of Kyrylo Mudryy as director on 27 Jan 2025

1 years ago on 7 Feb 2025

Appointment of Mr Vasily Fedorin as director on 27 Jan 2025

1 years ago on 7 Feb 2025

Resolutions

1 years ago on 17 Nov 2024